CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $62,000 | -36.1% | 10,717 | -25.1% | 0.00% | -33.3% |
| Q2 2020 | $97,000 | -36.2% | 14,300 | -40.0% | 0.00% | -40.0% |
| Q1 2020 | $152,000 | -39.0% | 23,835 | -0.1% | 0.01% | -16.7% |
| Q4 2019 | $249,000 | +159.4% | 23,855 | -2.8% | 0.01% | +100.0% |
| Q3 2019 | $96,000 | -78.4% | 24,540 | -18.1% | 0.00% | -75.0% |
| Q2 2019 | $445,000 | -36.3% | 29,955 | +6.3% | 0.01% | -36.8% |
| Q1 2019 | $699,000 | +133.8% | 28,173 | +69.2% | 0.02% | +111.1% |
| Q4 2018 | $299,000 | +8.3% | 16,652 | +454.9% | 0.01% | +12.5% |
| Q3 2015 | $276,000 | -23.3% | 3,001 | -26.8% | 0.01% | -20.0% |
| Q2 2015 | $360,000 | +61.4% | 4,099 | +36.6% | 0.01% | +66.7% |
| Q1 2015 | $223,000 | – | 3,001 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |